about
Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.Long-term protective immune response elicited by vaccination with an expression genomic library of Toxoplasma gondii.Immunological properties of gold nanoparticlesSpecific antibodies to Porphyromonas gingivalis Lys-gingipain by DNA vaccination inhibit bacterial binding to hemoglobin and protect mice from infection.Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes.Towards patient-specific tumor antigen selection for vaccination.Macaque multimeric soluble CD40 ligand and GITR ligand constructs are immunostimulatory molecules in vitroOncogenes in thyroid cancer.Novel approaches to therapeutic cancer vaccines.Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosisFlagellin Encoded in Gene-Based Vector Vaccines Is a Route-Dependent Immune Adjuvant.Assembly of erodible, DNA-containing thin films on the surfaces of polymer microparticles: toward a layer-by-layer approach to the delivery of DNA to antigen-presenting cells.Immune response to dna vaccine expressing transferrin binding protein a gene of Pasteurella multocida.DNA vaccines for targeting bacterial infections.Viral vaccines for bony fish: past, present and future.Immunogenicity and protective efficacy of DNA vaccine against visceral leishmaniasis in BALB/c miceImmune response induced in mice oral immunization with cowpea severe mosaic virus.IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice.Immune-mediated destruction of transfected myocytes following DNA vaccination occurs via multiple mechanisms.IP-10-encoding plasmid DNA therapy exhibits anti-tumor and anti-metastatic efficiency.A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation.Flagellin enhances saliva IgA response and protection of anti-caries DNA vaccine.Construction and immunogenic characterization of a fusion anti-caries DNA vaccine against PAc and glucosyltransferase I of Streptococcus mutans.Non-lethal viral challenge of influenza haemagglutinin and nucleoprotein DNA vaccinated mice results in reduced viral replication.A targeted fimA DNA vaccine prevents alveolar bone loss in mice after intra-nasal administration
P2860
Q27472925-B8DA0FCC-2CB7-4586-B1B6-89E8D3D692B3Q30786522-4AC6C447-AA2F-4ED8-B27C-3BBC6636A005Q33578950-C014CC76-17FD-4474-A77B-43AC17D2DEB8Q34007214-D3CCB707-513F-4EA8-B071-67CA4E9C7AF8Q34976868-7B5A2E21-A25E-4CDA-8713-E3D7AEB42C01Q35005960-7B5B6752-1099-4C7A-8C89-8E956EB007B1Q35160688-C9CAFC5A-248A-4F52-BE53-1ED402575C75Q35217001-43143D51-E5FD-4DEC-9EDB-B544F7EDC871Q35623327-A60511D9-C7A3-45CB-9E1E-643695D5713BQ36256428-257C0237-82FF-405B-8696-876D9F35C5F1Q36374782-DAA66CF7-5279-4E5E-9054-9AD864A2F2E5Q36546276-200C2C05-343D-4F01-85D9-7D0F13DD1346Q37153945-4122150C-F517-4B06-8606-32BEE6A29DC2Q37162315-CD37385D-D151-45E4-A57F-630B53111989Q37771943-068E470A-D830-415A-BEF0-B5EF200233C3Q38105343-70E77F2E-23B8-438C-A2FA-08D4ED2420A0Q40572422-D3BEC75F-9F67-4984-AC96-D3ADBBAC6CA1Q45731670-3ACA0B09-215C-4680-AB4F-AB5ACDD2426FQ45871399-35B99336-EA1A-4DA3-BEC3-CD0CDC5E32C3Q45880067-1DDB12A2-6F61-44B2-A3C5-5FEF9DCBDCC7Q47373704-53FA00DD-39D5-4F73-B295-C14A3BDDAC1BQ48509449-71F58DD1-A647-460E-A576-F52CC4AED540Q50034966-3BBC2271-AB64-46B7-972C-C0A016A0D690Q51022076-C68A7F12-D1D1-43F9-95FA-20615802F844Q51727725-43C08364-0156-47C2-8FB0-899544D73A4FQ56898983-95446DA0-6413-4FC3-94F0-81B68B758184
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Immune responses to DNA vaccines.
@ast
Immune responses to DNA vaccines.
@en
type
label
Immune responses to DNA vaccines.
@ast
Immune responses to DNA vaccines.
@en
prefLabel
Immune responses to DNA vaccines.
@ast
Immune responses to DNA vaccines.
@en
P356
P1476
Immune responses to DNA vaccines.
@en
P2093
P2888
P304
P356
10.1007/S000180050330
P577
1999-05-01T00:00:00Z